Literature DB >> 8670584

Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif.

H Tiwana1, C Wilson, P Cunningham, A Binder, A Ebringer.   

Abstract

The bacteria Proteus, Serratia, Escherichia and Pseudomonas possess sequences resembling the rheumatoid arthritis susceptibility sequence EQRRAA, but antibodies were elevated only to Proteus in 66 RA patients (P<0.001) when compared to 61 active ankylosing spondylitis patients and 60 controls.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8670584     DOI： 10.1093/rheumatology/35.6.592

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN： 0263-7103


  5 in total

1.  Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index.

Authors:  L E Hughes; S Bonell; R S Natt; C Wilson; H Tiwana; A Ebringer; P Cunningham; V Chamoun; E J Thompson; J Croker; J Vowles
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis.

Authors:  D M B T Disaanayake; Joan Faoagali; Hans Laroo; Gerald Hancock; Michael Whitehouse
Journal:  Inflammopharmacology       Date:  2014-01-05       Impact factor: 4.473

3.  Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis.

Authors:  H Tiwana; C Wilson; A Alvarez; R Abuknesha; S Bansal; A Ebringer
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis.

Authors:  T Rashid; M Leirisalo-Repo; Y Tani; S Hukuda; S Kobayashi; C Wilson; S Bansal; A Ebringer
Journal:  Clin Rheumatol       Date:  2004-02-13       Impact factor: 2.980

Review 5.  Rheumatoid arthritis is linked to Proteus--the evidence.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 3.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.